Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB

Cancer Research
Zhiping ZengHu Zhou

Abstract

Retinoid X receptor alpha (RXRα) and its N-terminally truncated version, tRXRα, are widely implicated in cancer development and represent intriguing targets for cancer prevention and treatment. Successful manipulation of RXRα and tRXRα requires the identification of their modulators that could produce therapeutic effects. Here, we report that a class of nitrostyrene derivatives bind to RXRα by a unique mechanism, of which the nitro group of nitrostyrene derivatives and Cys432 of RXRα are required for binding. The binding results in the potent activation of Gal4-DBD-RXRα-LBD transactivation. However, the binding inhibits the transactivation of RXRα homodimer, which might be due to the distinct conformation of RXRα homodimer induced by these nitrostyrene derivatives. Two RXRα point mutants with Cys432 substituted with Tyr and Trp, respectively, could mimic the bindings of two nitrostyrene derivatives and have the ability of autotransactivation. In studying the functional consequences of the binding, we show that these nitrostyrene derivatives could potently inhibit the TNFα/NFκB signaling pathway in a tRXRα-dependent manner. tRXRα promotes TNFα-induced NF-κB activation through its interaction with TRAF2 and enhances TNFα-induced ...Continue Reading

References

Jul 29, 2000·Bioorganic & Medicinal Chemistry Letters·A R FathiH J Steinfelder
Mar 5, 2002·Nature Immunology·Michael Karin, Anning Lin
Dec 21, 2004·Cell Death and Differentiation·A SzantoL Nagy
Feb 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Francisco J SchopferBruce A Freeman
Nov 12, 2005·The New England Journal of Medicine·Robert A Hegele
Oct 2, 2007·Nature Reviews. Drug Discovery·Lucia AltucciHinrich Gronemeyer
Oct 2, 2007·Nature Reviews. Drug Discovery·Angel R de LeraHinrich Gronemeyer
Oct 3, 2007·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fotini NaoumSerkos A Haroutounian
Jul 8, 2008·Nature Structural & Molecular Biology·Yong LiH Eric Xu
Mar 10, 2009·EMBO Reports·Albane le MaireWilliam Bourguet
Sep 5, 2009·Bioorganic & Medicinal Chemistry·Rémy Le GuévelGilles Salbert
Jan 26, 2011·Journal of Molecular Biology·Haitao ZhangXu Shen
Jul 5, 2011·Biochimica Et Biophysica Acta·Anne C Geisler, Tanja K Rudolph
Oct 25, 2011·Biochimica Et Biophysica Acta·Marcia I Dawson, Zebin Xia
Sep 18, 2012·Free Radical Biology & Medicine·Ana M FerreiraHomero Rubbo
Oct 23, 2012·Cancer Letters·Wen-Ming Chu
Nov 16, 2012·Cancer Research·Guang-Hui WangXiao-Kun Zhang
Jan 22, 2013·Nature Reviews. Drug Discovery·Michael CroftCarl F Ware
Feb 8, 2013·Carcinogenesis·Weiwei GaoXiao-kun Zhang
Mar 6, 2013·The Journal of Pathology·John P WatersJohn R Bradley
Jun 14, 2013·Journal of Molecular Signaling·Ping Xie

❮ Previous
Next ❯

Citations

Oct 24, 2015·Acta Biochimica Et Biophysica Sinica·Xiaokun ZhangYing Su
Nov 16, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michelle A SugimotoEmerson Silva Lima
Jul 13, 2019·Expert Opinion on Therapeutic Patents·Simone Schierle, Daniel Merk
Aug 11, 2018·Cellular & Molecular Biology Letters·Liqun ChenYiyi Zhao
Aug 15, 2018·International Journal of Molecular Sciences·Masaki Watanabe, Hiroki Kakuta
May 14, 2017·Cancer Chemotherapy and Pharmacology·Yen-Yun WangShyng-Shiou F Yuan
Jan 12, 2019·European Journal of Medicinal Chemistry·Zhiqiang YanYing Su
Oct 8, 2019·European Journal of Medicinal Chemistry·Yunyuan HuangJian Wan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis